OR WAIT null SECS
July 31, 2023
The new facility is set to utilize and extend SCG's capabilities in advanced cell therapy manufacturing and off-the-shelf human-induced Pluripotent Stem Cell (iPSC) technology.
July 28, 2023
Pandemic, PBM, and other policies on hold during the summer recess.
The expansion project is aimed to be completed in December 2024 and the new facility will be fully operational by 2025.
July 27, 2023
Tarsus Pharmaceuticals’ Xdemvy (lotilaner ophthalmic solutions) is designed to treat Demodex blepharitis by directly targeting Demodex mites.
July 25, 2023
The damage to the facility, which produces 8% of US injectable drug consumption, should not significantly affect the current supply.
July 24, 2023
The framework is now expanded beyond COVID-19 vaccines and treatments.
The paper highlights the potential of AI in the medicinal product lifecycle and the approach that developers should take with it.
July 20, 2023
These recommendations will keep key antibiotics for respiratory infections available when they are needed most.
The document’s recommendations outline what studies and reports are required for changes to cell and gene therapy manufacturing.
The new drug may help vulnerable children resist RSV in the coming fall and winter season.